Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBT (2020 - 2025)

Stemtech's EBT history spans 6 years, with the latest figure at -$812541.0 for Q3 2025.

  • For Q3 2025, EBT rose 30.64% year-over-year to -$812541.0; the TTM value through Sep 2025 reached -$3.0 million, up 43.43%, while the annual FY2024 figure was -$3.8 million, 30.55% up from the prior year.
  • EBT for Q3 2025 was -$812541.0 at Stemtech, down from -$296280.0 in the prior quarter.
  • Across five years, EBT topped out at $17.4 million in Q3 2022 and bottomed at -$25.0 million in Q2 2022.
  • The 5-year median for EBT is -$812541.0 (2025), against an average of -$1.4 million.
  • The largest YoY upside for EBT was 426.83% in 2022 against a maximum downside of 3130.65% in 2022.
  • A 5-year view of EBT shows it stood at -$848155.0 in 2021, then soared by 47.4% to -$446114.0 in 2022, then tumbled by 317.83% to -$1.9 million in 2023, then skyrocketed by 78.72% to -$396580.0 in 2024, then plummeted by 104.89% to -$812541.0 in 2025.
  • Per Business Quant, the three most recent readings for STEK's EBT are -$812541.0 (Q3 2025), -$296280.0 (Q2 2025), and -$1.5 million (Q1 2025).